Journal Mobile Options
Table of Contents
Vol. 24, No. 3-4, 2006
Issue release date: July 2006
Section title: Paper
Dig Dis 2006;24:342–347
(DOI:10.1159/000092887)

Frequency of Functional Bowel Disorders among Healthy Volunteers in Mexico City

Schmulson M.a, b · Ortíz O.c · Santiago-Lomeli M.a · Gutiérrez-Reyes G.a · Gutiérrez-Ruiz M.C.d · Robles-Díaz G.a, b · Morgan D.e
aLiver, Pancreas and Motility Laboratory (HIPAM), Department of Experimental Medicine, Faculty of Medicine, Universidad Nacional Autonoma de Mexico-UNAM, bGastroenterology Department, Clinica Lomas Altas S.C., cDepartment of Internal Medicine, Centro Medico Nacional Siglo XXI, and dDepartment of Health Sciences, Universidad Autonoma Metropolitana-UAM, Iztapalapa, Mexico City, Mexico; eDivision of Gastroenterology, University of North Carolina, Chapel Hill, N.C., USA
email Corresponding Author

Dr. Max Schmulson

Departamento de Medicina Experimental, Facultad de Medicina

Universidad Nacional Autónoma de México (UNAM), Hospital General de México

Doctor Balmis #148, Col. Doctores, CP 06726, Del. Cuahutemoc, México DF (Mexico)

Tel. +52 5556 232 673, Fax +52 5556 232 669, E-Mail maxjulio@avantel.net


References

  1. Huerta I, Valdovinos MA, Schmulson M: Irritable bowel syndrome in Mexico. Dig Dis 2001;19:251–257.
  2. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA: Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):II43–II47.
  3. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, The Rome II Multinational Working Teams: The Functional Gastrointestinal Disorders, ed 2. McLean/VA, Degnon Associates, 2000.
  4. Sperber A, DeVellis RF, Boehlecke B: Cross-cultural translation. Methodology and validation. J Cross Cult Psychol 1994;25:5001.
    External Resources
  5. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–1456.
  6. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodriguez-Artalejo F: Symptoms of gastroesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004;19:95–105.
  7. Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: a technical review for practice guidelines development. Gastroenterology 1997;112:2120–2137.
  8. Kang JY: Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005;21:663–676.
  9. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L: Functional gastrointestinal disorders in Canada. First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225–235.
  10. Lu CL, Chen CY, Lang HC, Luo JC, Wang SS, Chang FY, Lee SD: Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment Pharmacol Ther 2003;18:1159–1169.
  11. Kwan ACP, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, Leelakusolvong S, Luo JY, Manan C, Park HJ, Piyaniran W, Qureshi A, Long T, Xu GM, Xu L, Yuen H: Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18:796–802.
  12. Gwee KA, Wee S, Wong ML, Png DJ: The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004;99:924–931.
  13. Celebi S, Acik Y, Deveci SE, Bahcecioglu IH, Ayar A, Demir A, Durukan P: Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004;19:738–743.
  14. Saito YA, Talley NJ, Melton J, Fett S, Zinsmeister AR, Locke GR: The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003;15:687–694.
  15. Talley NJ, Boyce P, Jones M: Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42:690–695.
  16. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B: Gender-related differences in IBS symptoms. Am J Gastroenterol 2001;96:2184–2193.
  17. Simren M, Abrahamsson H, Svedlund J, Bjornsson ES: Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545–552.
  18. Talley NJ: Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004;4(suppl 2):S3–S10.
    External Resources
  19. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al: US householder survey of functional gastrointestinal disorders. Dig Dis Sci 1993;38:1569–1580.
  20. Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E, Lipton RB, Farup CE: Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999;94:3530–3540.
  21. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L: An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001;96:3130–3137.
  22. Ortiz O, Schmulson M: Calidad de Vida de los pacientes con estreñimiento crónico de acuerdo al tránsito colonico con marcadores radioopacos. Servicio Social en Investigación, Secretaría de Salud, México 2005.
  23. Whitehead WE, Wald A, Diamant NE, Enck P, Pemberton JH, Rao SS: Functional disorders of the anus and rectum. Gut 1999;45(suppl II):II55–II59.
  24. Wald A: Functional anorectal and pelvic pain. Gastroenterol Clin North Am 2001;30:243–251.